Early effects of mood stabilizers on the Akt/GSK-3β signaling pathway and on cell survival and proliferation.

Bibliographic Details
Published in:Psychopharmacology Vol. 205; no. 3; pp. 419 - 430
Main Authors: Aubry, Jean-Michel, Schwald, Michèle, Ballmann, Eladia, Karege, Félicien
Format: Journal Article
Published: Springer Nature Aug2009
Online Access:View this record in EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=104334979&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 104334979
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        00333158
        EJD
      jtl: Psychopharmacology
      issn: 00333158
      maglogo: N
    pubinfo:
      dt: Aug2009
      vid: 205
      iid: 3
      pid: 237
      pub: Springer Nature
      place: New York, New York
    artinfo:
      ui:
        104334979
        2011956302
        10.1007/s00213-009-1551-2
        104334979
      ppf: 419
      ppct: 11
      formats:
        fmt:
          @attributes:
            type: P
      tig:
        atl: Early effects of mood stabilizers on the Akt/GSK-3β signaling pathway and on cell survival and proliferation.
      aug:
        au:
          Aubry, Jean-Michel
          Schwald, Michèle
          Ballmann, Eladia
          Karege, Félicien
        affil: Department of Psychiatry, Bipolar Program, Geneva University Hospitals and University of Geneva, 6-8 rue du 31 Décembre, CH-1207 Geneva, Switzerland
      sug:
      pubtype: Academic Journal
      doctype: Journal Article
      ougenre: Article
      ab:
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N